Boston Scientific reported June-quarter revenue of $5.44B, up 7.5% year over year. The topline growth suggests a modestly improving demand backdrop in its core interventional medical specialties, though no guidance or margin details were provided in the excerpt.
Boston Scientific reported June-quarter revenue of $5.44B, up 7.5% year over year. The topline growth suggests a modestly improving demand backdrop in its core interventional medical specialties, though no guidance or margin details were provided in the excerpt.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
